Status:
TERMINATED
Nitrofurantoin and Urinary Tract Infections (UTIs)
Lead Sponsor:
University of Pittsburgh
Conditions:
Urinary Tract Infections
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Urinary tract infection (UTI) is the most common complication after surgery for prolapse or urinary incontinence. UTIs are painful and have the potential to turn into kidney infections. We are asking ...
Detailed Description
Abstract: Specific aim: to determine if extended release nitrofurantoin antibiotic prophylaxis administered to patients performing clean intermittent self-catheterization (CISC) after pelvic organ pr...
Eligibility Criteria
Inclusion
- Women who fail a post-operative voiding trial and are willing to learn clean intermittent self-catheterization (CISC) prior to discharge from the hospital
Exclusion
- Known drug allergy to nitrofurantoin
- A history of renal insufficiency
- Renal transplant
- Renal nephropathy
- A recent history of more than 3 Urinary Tract Infections (UTIs) per year
- Known immunocompromised condition (organ transplant, chemotherapy for cancer or arthritis, autoimmune diseases (lupus etc)).
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00678041
Start Date
May 1 2008
End Date
May 1 2009
Last Update
September 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Magee Womens Hospital
Pittsburgh, Pennsylvania, United States, 15213